Charlotte Lozier Institute, Author at Lozier Institute

404 results

Continued Attempts to Regulate Pro-life Pregnancy Help Centers Amount to “Lipstick on a Pig”

Illinois HB4221 amounts to nothing more than “lipstick on a pig” in that it is merely another attempt, in a long line of similar attacks, to legislate pro-life pregnancy help centers out of existence. In doing so, the proposed bill ignores the needs of women, the near-unanimous gratitude they express for the services they receive at centers, and numerous court rulings that have affirmed the centers’ freedom of operation and awarded them judgments against jurisdictions seeking to harass them.

Jeanneane Maxon, J.D.

January 14, 2023

ClosePlease login

Women’s Healthcare at its Finest

Over 2,700 Pregnancy Resource Centers (PRCs), also known as Pregnancy Help Centers or simply Pregnancy Centers, dot the landscape across the United States today. The majority of these centers offer clinical medical services for pregnant women in need and seek to support women who are facing an unplanned pregnancy. 

Karysse J. Hutson, D.O., FACOOG

December 21, 2021

ClosePlease login

Fetal Pain, Following the Evidence

During the Dobbs abortion case hearing, Justice Sotomayor made a number of problematic statements. She was unfamiliar with decreases in the edge of viability since Roe was handed down (28 weeks then versus approximately 22 weeks gestation today, with an increasing number of infants surviving at 21 weeks. As a neonatologist, I found perhaps even more distressing her claim that premature babies who are less than 25 weeks gestation cannot feel pain.

Robin Pierucci, M.D., M.A.

December 21, 2021

ClosePlease login

Analysis: FDA Decision Ignores Data on Complications, Puts Women at Risk

As a dangerous drug, mifepristone has been subject to regulations put in place by the Food and Drug Administration (FDA) in 2000.[1] Under these regulations, called a Risk Evaluation and Mitigation Strategy (REMS), mifepristone may only be dispensed in person by certain qualified medical providers.

Tessa Longbons

December 16, 2021

ClosePlease login

Chemical Abortion: FDA Ignores ‘Inconvenient’ Science and Data Confirming Public Health Threat

The U.S. Food and Drug Administration (FDA) today announced plans to irresponsibly erode longstanding patient safeguards on the abortion pill, despite major U.S. and international research confirming that chemical abortion has led to a surge in emergency room visits and higher rates of complications.

Charlotte Lozier Institute

December 16, 2021

ClosePlease login

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to hide the widespread dangers of unwanted and contraindicated abortions.

David C. Reardon, Ph.D.

Donna Harrison, M.D.

December 16, 2021

ClosePlease login

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates of complications.

Charlotte Lozier Institute

December 15, 2021

ClosePlease login

Public Health Threat: Colorado DPHE Data Reveals Dramatic Increase in Risky Abortion Method

The most recent State of Colorado abortion data shows a dramatic increase in the use of potentially dangerous abortion drugs which multiple peer-reviewed studies have linked to higher rates of complications.

Charlotte Lozier Institute

December 13, 2021

ClosePlease login